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Deep brain stimulation (DBS) in the thalamic ventrointermediate nucleus (VIM) is the traditional target for the
surgical treatment of pharmacologically refractory essential tremor or parkinsonian tremor. Studies in recent years
on DBS in posterior subthalamic area (PSA), including the zona incerta and the prelemniscal radiation, have shown
promising results in tremor suppression, particularly for those tremors difficult to be well controlled by VIM DBS,
such as the proximal postural tremor, distal intention tremor and some cerebellar outflow tremor in various
diseases including essential tremor and multiple sclerosis. The adverse effect profile of the PSA DBS is mild and
transient, without lasting or striking dysarthria, disequilibrium or tolerance, in contrast to VIM DBS, particularly
bilateral DBS. However, the studies on PSA DBS so far are still limited, with a handful of studies on bilateral PSA, and
a short follow up duration compared to VIM. More studies are needed for direct comparison of these targets in the
future. A review here would help to gain more insight into the benefits and limits of the PSA DBS compared to
that in VIM in the clinical management of various tremors, particularly for those difficult to be well controlled by
traditional VIM DBS.
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Deep brain stimulation (DBS) in thalamic ventrointer-
mediate (VIM) nucleus is the traditional target for the
surgical treatment of pharmacologically refractory essen-
tial tremor (ET) or parkinsonian tremor. Studies in re-
cent years on DBS in the posterior subthalamic area
(PSA), including the zona incerta (Zi) and the prelemnis-
cal radiation (Raprl), have shown promising results in
tremor suppression [1-25], particularly for those difficult
to be controlled by VIM DBS, such as the proximal pos-
tural tremor, distal intention tremor and some cerebellar
outflow tremor in ET, multiple sclerosis (MS), post-
traumatic tremor (PTT), cerebellar tremor (CT), Holmes
tremor (HT) and spinocerebellar ataxia 2 (SCA2)
[8,12-14,16]. The adverse effect profile of the PSA DBS
is mild and transient, without lasting or striking dysarth-
ria, disequilibrium or tolerance, as would have been seen
in the VIM DBS, particularly bilateral DBS [26-30].
However, the studies on PSA are still limited given less* Correspondence: txie@bsd.uchicago.edu
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reproduction in any medium, provided the orthan 30 publications in the PubMed so far, with even a
handful of studies performed on bilateral PSA, and a
short follow up duration compared to VIM. Therefore, a
mini-review on DBS in PSA is needed to gain more
comprehensive insight into the potential benefits and
limits of the PSA DBS compared to that in VIM DBS in
the clinical management of various tremors, particularly
for those tremors difficult to be well controlled by trad-
itional VIM DBS.DBS in PSA: evidence on effective tremor control
and others
Anatomically, the PSA is bounded anteriorly by the pos-
terior border of the subthalamic nucleus (STN), super-
iorly by the ventral thalamic nuclei, inferiorly by the
dorsal border of the substantia nigra, posteriorly by the
medial lemniscus, posteromedially by the anterolateral
border of the red nucleus, posterolaterally by the ventro-
caudal nucleus, and laterally by the posterior limb of the
internal capsule [31]. It consists of Zi and the Raprl. The
Zi lies dorsal and posterior to STN, joining both the
basal gangalia thalamocortical circuit and the cerebellar
thalamocortical circuit. The Zi anatomically also consists. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 PSA DBS publications: indications, targets, results and side effects





Mundinger, 1977 [1] 7 torticollis, unilateral,
stimulation 30-40 minutes.
cZi; in some cases combined
with other structures













Transient worsening of swallowing,
speech, and micturition, all resolved in
3 weeks but dysarthria.
Andy, 1983 [3] 1 PTT, unilateral 7mm lateral/ 8.5mm behind





Kitagawa et al., 2000 [4] 1 ET and 1 DT, unilateral,
intra-op stimulation and
post-op 1 week
Zi, 3 mm under the border
of the VIM
Abolition of ET; “remarkable”
decrease in DT and dystonia
Transient paresthesia, palm hyperhidrosis,
anorexia, and disequilibrium
Hooper et al., 2001 [5] 1 PTT, unilateral,
post-op 44 months




Shoulder weakness, resolved in 3 days.
Velasco et al., 2001 [6] 10 PD, unilateral,
post-op 12 months
Expressed in tenths of the ICL:
laterality 5/10, 8/10 behind AC,






1 worsening pre-existing depression,
1 transient diplopia, 3 transient dysarthria
Murata et al., 2003 [7] 8 ET, unilateral,
post-op 22 months (8-42)
Best 11mm lateral/7.5mm behind




Only stimulation induced that did not
affect result.
Nandi and Aziz, 2004 [8] 15 MS, 6 bilateral, 9 unilateral,
post-op 15 months in 10 patients
Zi Contralateral postural tremor
decreased by 64%,
intention tremor by 36%
Transient paresthesia, mild dysarthria and
seizure in 1 and infection in 2 patients.
Plaha et al., 2004 [9] 4 ET, bilateral, post-op 12 months Medial to the posterior dorsal
third of the STN
Total tremor decreased by




No dysarthria or dysequilibrium.




UPDRS-III improved by 44.3%,
tremor by 78.3%, rigidity by
92.7% and akinesia by 65.7%.
Mild adverse events
Plaha et al., 2006 [11] 35 PD, 29 bilateral, 6 unilateral,
post-op 6 months
cZi: posteromedial to the
post-dorsal STN
cZi better than STN in reducing
UPDRSIII by 76%, tremor by 93%,
rigidity by 76% and bradykinesia
by 65% in cZi vs by 55%, 61%,
50% and 59% in STN.
No complication in Zi No difference
in dyskinesia, L-dopa reduction, and
stimulation parameters.
Freund et al., 2007 [12] 1 SCA2, bilateral, post-op 2 years Combined VOP-VIM/Zi-Cerebellar
thalamic projection (VOP: ventro-
oralis posterior).
Nearly complete cessation of
tremor and torticollis
by stimulation to distal contacts
No complication mentioned
Hamel et al., 2007 [13] 8 ET, 2 MS, 1 SCA, bilateral, post-op
at least 3 months, most of them > 1year
12.7mm lateral/7mm behind
MCP/1.5mm below ICL
Reducing intention tremor by
68% to 73%. PSA better
















Table 1 PSA DBS publications: indications, targets, results and side effects (Continued)
than VIM unless limited by
side effects
Herzog et al., 2007 [14] 10ET, bilateral, and 11MS, 6 bilateral,
5 unilateral, post-op at least 4 months
In PSA region, no details PSA better than VIM in postural
and intention tremors
reduction, by 64% in ET and by
50% in MS.
Unknown
Carrillo-Ruiz et al., 2008 [15] 5 PD, bilateral, post-op 12 months Active contacts: 11.5mm/ 6.5mm
behind MCP and 4.5mm below ICL
UPDRS III decreased by 65%,
tremor by 90%, rigidity
by 94%, bradykinesia by 75%
1 deterioration of pre-existing depression,
5 transient somnolence, 1 transient dysarthria
Plaha et al., 2008 [16] 6 ET, 5 PD, 4 MS, 1 CT, 1 HT,
1 DT/bilateral, post-op 12 months
Posteromedial to the
posterodorsal STN
PD tremor improved by 92%,
rigidity by 77%,
bradykinesia by 62%. Tremor
improved in ET by 76%;
MS, 57%; CT, 60%; HT, 70%;
DT, 71%. Low volts
2 transient dysequilibrium,
1 transient dysphagia
Blomstedt et al., 2009 [17] 2DT,1 WC (writer’s cramp),1CT,
all unilateral, post-op 1 year
Active 10.3mm/6.1mm behind
MCP/3.5 below ICL, in PSA
87% tremor reduction Unknown
Blomstedt et al., 2010 [18] 21ET, 2 bilateral, 19 unilateral,
post-op 1 year.
PSA active contact 11.6mm
lateral/6.3mm behind MCP/3mm
below ICL.
Reducing tremor of upper
extremity by 95%,
hand function by 87%,
improving ADL by 66%.
8 transient expressive dysphasia, 1 transient
clumsy hand and leg.
Fytagoridis and
Blomstedt, 2010 [19]
27 ET, 8 PD, 2 DT, 1 CT, 1 WC, all
unilateral except 4 bilateral,
unknown disease, post-op 34 months
Active 12.0mm/6.1mm behind
MCP/1.5mm below ICL, all in PSA
24 non-PD tremor
decreased by 91%
1 transient hemiparesis, 1 infection, 22%
transient dysphasia.
Barbe et al., 2011 [20] 21ET, bilateral 19, 2 unilateral,
post-op at least 3 months
26 sub- ICL and 14 above
ICL electrodes. The mean
sub-ICL 11.3mm lateral/7.2mm
behind MCP/1.4mm below
ICL, the thalamic 12.6mm
lateral/5.7mm behind MCP/1.0mm
above ICL.






Paresthesia in 3/26, and dysarthria in 2/26
electrodes
Blomstedt et al., 2011 [21] 4 ET unilateral, one in STN one
in cZi, post-op 1-6 years
cZi 9.5-15.5mm lateral/1.3-9.4mm
behind MCP/0.2mm above to
6.8mm below ICL
cZi more efficient than STN Comparable, dysarthria, dystonia,
dizziness, blurred vision.
Blomstedt et al., 2011 [22] 5ET, failed VIM, no info on
post-op duration except in “years”
cZi, 11.4mm lateral/6.8mm
behind MCP/2.9mm below ICL
cZi achieved improvement
in tremor control after
VIM failed, 57% cZi vs
25% VIM
Unknown
Blomstedt et al., 2011 [23] 68 ET, 34VIM and 34 PSA, only 3 each
bilateral, post-op 28 months for VIM
and 12 month for PSA.
Vim 13-15mm lateral/6-7mm before
PC/0mm on ICL. PSA: posteromedial
to the tail of the STN at the level of
maxim diameter red nucleus
(PC: posterior commissure)
Tremor in the treated hand
improved by 70% in VIM
and 89% in PSA.
Unknown
Blomstedt et al., 2012 [24] 14 PD, 13 unilateral, 1 bilateral,
post-op 18 months
Posterior and medial to the
posterior tail of the STN at
















Table 1 PSA DBS publications: indications, targets, results and side effects (Continued)
the maximal diameter of
the RN. Active contact 12.6mm
lateral/7mm post MCP/2mm
below ICL
Tremor reduction by 82.2%,
rigidity by 34.3%,
bradykinesia by 26.7%
Fytagoridis et al., 2012 [25] 18 ET, 16 unilateral and 2 bilateral,
post-op 4 years on average
cZi, 12.0mm lateral/6.3mm
behind MCP/2.2mm
below ICL, in posterior-medial
to STN at the level of the
maximal diameter of red
nucleus
Improved total tremor by 51.4%,
upper extremity
by 89.4%, hand function by 78.5%.
No increase in stimulation over
the course
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dle that lies posterior to the STN, separated from it by
the intervening Zi. It contains fibers from the mesen-
cephalic reticular formation that projects to the thal-
amus as well as ascending cerebellothalamic fibers. The
Forel H1 (thalamic fasciculus) and H2 (lenticular fascic-
ulus) lies dorsal to the STN and immediately anterior to
the PSA, and the Forel H lies anterior to the red
nucleus.
Whilst the Zi was a target for lesioning since the early
sixties, DBS in PSA was first reported by Mundinger in
1977 [1]. The intraoperative stimulation of the Zi and
surrounding area obtained good control of torticollis in
7 patients without complications [1]. Successful results
were also reported by Brice and McLellan in 1980 and
Andy in 1983 [2,3]. The unsophisticated DBS devices,
the successful therapeutic effects of levodopa in
Parkinson’s disease (PD), and the successful DBS on
VIM by Benabid in 1987 [32] are all possible reasons for
the lack of sufficient reports during that period of time.
In 2000, a successful attempt on the DBS targeting Zi in
controlling intention tremor in ET and dystonic tremor
(DT), which were hard to be controlled otherwise by
DBS targeting VIM, was reported by Kitagawa et al. [4].
This study reignited the interest of DBS targeting Zi and
more broadly PSA. Since then, more than 20 articles
have been published, as listed in the Table 1, including
201 cases of ET, 99 cases of PD, 32 cases of MS, 6 cases
of DT, and several others (PTT, CT, HT, WC, and SCA)
[1-25]. The majority of the DBS was placed unilaterally.
Only about 25% of the cases had bilateral DBS (Table 1).
They were followed up for 3 months to 6 years. Most of
them were targeting caudal Zi (cZi), with different para-
meters among studies. The therapeutic benefit was
prominent, particularly for those tremors difficult to be
controlled by VIM, such as proximal postural tremor,
distal intension tremor and cerebellar out flow tremor.
The complications mostly were mild and transient.
There was no lasting or striking dysphasia, dysarthria, or
disequilibrium, which could be encountered in VIM
DBS, particularly bilateral VIM DBS [26-29]. There was
no tolerance either [9,25], another unfavorable feature
often reported in VIM DBS [30]. The effect on axial
symptoms, such as vocal tremor, head tremor and swal-
lowing function, was rarely mentioned [9]. A good effect
on neck tremor was reported on bilateral cZi DBS [9].
DBS on cZi was not found to have negative effect on the
swallowing function [33], but have slightly different ef-
fect on voice compared to STN DBS [34].
The difference in the specific targets of PSA, the num-
ber of DBS placed (unilaterally vs bilaterally), the post-
surgical follow -up, and the different diseases studied
among these articles makes a concise comparison of
clinical benefits and limits of PSA with VIM difficult. Asite-to-site comparison among different patients could
be more helpful to delineate the difference between the
targets. One of the good examples was the study by
Hamel et al. [13], who found that cZi DBS at the para-
meters of 12.7 mm lateral, 7.0 mm posterior and 1.5
mm ventral to the mid-commisural point (MCP) pro-
vided better outcome than VIM DBS. Though it is a
retrospective study with different post-surgical duration,
the site-to-site comparison did provide more reliable
comparison of these two targets. A similar result was
also reported by another group [11,20,21], with electro-
des below the intercommissural line (ICL) producing
better outcome in tremor control than those above the
ICL [20], though the better outcome meant to be more
efficient for cZi than VIM rather than significant differ-
ence in individual or maximal stimulation response in
these two targets in some studies [20]. More recently, a
prospective study designed for direct comparison of
PSA/cZi with VIM in each individual patient was pre-
sented to the 16th MDS meeting in Dublin [35]. The
electrode in the study was placed across both PSA/cZi
and VIM, which would allow precisely comparing these
two targets in the same patient, with both targets tar-
geted in the same side of the brain, or with one target in
one side of the brain and the other target in the other
side of the brain of the same patient. This design avoids
the confounding difference in the disease severity, post-
surgical duration, and skills/targets in assessing the DBS
efficacy, and allows more accurate site specific assess-
ment (Zi vs VIM). A significantly better outcome in gen-
eral was found in stimulating cZi than VIM, except that
some of the patients could not tolerate the adverse
effects of paresthesia in cZi despite the best control of
the tremor. The vocal tremor and head tremor were also
very well controlled by the stimulation. No worsening of
gait was observed after the surgery. The study shows
very promising tremor control by cZi DBS, though the
conclusion is limited by the small sample size of five
patients, as acknowledged by the authors [35]. Stimulat-
ing bilateral VIM was also reported to improve vocal
tremor and head tremor in some studies as reviewed by
Lyons and Pahwa [36], however the occurrence and the
worsening of dysarthria and disequilibrium were the
concerns in choosing bilateral VIM stimulation in some
cases [26-29], and made unilateral VIM DBS as an alter-
native in certain circumstances [37]. The lack of lasting
dysarthria and disequilibrium reported even in bilateral
cZI DBS is probably because the cZi DBS only overrides
tremor oscillations without interrupting patterns of in-
formation related to fine movements of vocal cords and
proprioceptive sensation [16].
Besides effective tremor control [11,21,24], cZi was
also found to be better than STN in controlling rigidity
and bradykinesia without difference in reducing
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ity and bradykinesia was not found to be very well con-
trolled by cZi DBS in another study though [24].
Dystonia was also found to be well controlled by cZi
DBS [1,16,17]. More recently, cZi in combination with
pedunculopontine nucleus was found to have positive ef-
fect on axial symptoms [38]. cZi DBS could also be a tar-
get for some patients with ataxia [39].
DBS in PSA: targeting the targets
As neither cZi nor Raprl can be reliably distinguished on
1.5 Tesla MRI, some used the neighboring structures as
reference, such as the STN or VIM, to guide the DBS
placement. Most of the studies used posterior and med-
ial to the posterior tail of the STN at the maximal diam-
eter of the red nucleus as the target (Table 1). Some of
them used the 2-3mm under the ventral border of the
VIM as the target [4,35]. Only a few studies also used
microelectrode recording to guide the electrode place-
ment, as cZi gives silent or low activity neuronal back-
ground [35], which differentiates cZi from VIM. Imaging
targeting in combination with macrostimulation was ap-
plied virtually by all studies.
Specifically, the PSA was identified on trans-axial T2-
weighted MRI images slightly posterior medial to the
subthalamic nucleus at the level of the maximal diam-
eter of the red nucleus (Table 1), or about 2-3mm below
the ventral border of the VIM [4,35]. A pre-operative
MRI fused with a head CT with stereotactic frame and
superimposed digitized Schaltenbrand stereotactic atlas
was used to plan the trajectory. The electrode was
implanted under local anesthesia. EMR was further used
in some studies [35]. The final position of the electrode
was dictated by the response to the macrostimulation. A
postoperative x-ray was performed before removal of the
frame. The location of each electrode contact post-
surgically was determined on the postoperative CT
infused with the pre-surgical MRI and superimposed
atlas. The DBS contact location was determined in rela-
tion to the anterior commissure (AC) – posterior com-
missure (PC) line and the coordinates were plotted onto
the Schaltenbrand stereotactic atlas. The efficacy of the
stimulation was presented as the result on stimulation in
relation to the result off stimulation at the same evalu-
ation, based on clinical exam, UPDRS motor scores,
tremor rating scores, daily living function, or quality of
life assessment.
DBS in PSA: possible mechanism
The mechanism of tremor suppression by stimulation in
PSA (mostly in cZi) is not entirely clear. The Zi is a
heterogenous nucleus that lies at the base of the dorsal
thalamus and is an extension of the reticular /thalamic
nucleus [40]. Its rostral component extends over thedorsal and medial surface of the STN, and its caudal or
motor component lies posteromedial to the STN [41,42].
The ZI receives afferents from the globus pallidus
internus (GPi), the substantia nigra reticulate (SNr)
[41,43,44], the ascending reticular activating system
[43-45], the interpositus nucleus of the cerebellum, and
also the motor, associative and limbic areas of the cere-
bral cortex [43,46]. The ZI sends efferents to the centro-
median and parafascicular nuclei [47-49], the ventral
anterior nucleus and the ventral lateral nucleus of the
thalamus [50], the midbrain extrapyramidal area and the
medial reticular formation [41], the GPi and SNr [41],
the interpositus nucleus of the cerebellum, the inferior
olive and cerebral cortex [51-53]. Current hypotheses
regarding the mechanisms of tremor generation point to
abnormal synchronisation of neuronal firing in the basal
ganglia thalamocortical loop (in PD and DT) or the cere-
bellar thalamocortical loop (in ET, CT and MS tremor)
or both loops (HT) [16]. cZi is an effective target for the
surgical control of all forms of tremor because of its
unique GABAergic connections with both the basal gan-
glia and cerebellar thalamocortical loops, in addition to
the brain stem motor effectors through which tremor
oscillation may be transmitted [16]. Stimulation of the
Zi is likely to suppress the tremor by overriding the
oscillations in these areas [16]. Stimulation of the Raprl
could similarly abolish contralateral tremor and reduce
rigidity [54]. The Raprl is a fiber bundle that lies poster-
ior to the STN, separated from it by the intervening Zi,
and consists of fibers from the mesencephalic reticular
formation that project to the thalamus as well as ascend-
ing cerebellothalamic fibers. How much of the stimula-
tion of the ZI overflows into the neighboring Raprl is
unknown and may vary according to individual electrical
conductivity of these structures in individual patients.
The exact mechanism of how stimulation of PSA sup-
presses various tremors still awaits further studies to
corroborate.Conclusion
PSA could potentially be an alternative target for the
tremor, particularly for those tremors difficult to be con-
trolled by traditional VIM DBS, including the proximal
postural tremor, distal intention tremor, and some cere-
bellar outflow tremor. The effect of PSA DBS on axial
head tremor and vocal tremor also seems to be promis-
ing. The adverse effect profile of the PSA appears transi-
ent and mild. However, the conclusion is limited by the
small numbers of studies so far. More studies, including
randomized double-blinded trials comparing the effect
of DBS targeting PSA with that targeting VIM, are
needed to help us better understand the efficacy and ad-
verse effect profile of the PSA DBS, which could have
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difficult to be controlled by traditional VIM DBS.
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